Cell populations from the Innate Lymphoid Cell (ILC) family are involved in many early response defense mechanisms and tissue homeostasis. 1 They resemble T-lymphocytes in cytokine responses, but lack T-cell receptor and recombinant activating gene (RAG) re-arrangement and thus respond directly to stimuli locally by producing large amounts of cytokines. Based on their expression of lineage-defining transcription factors, the ILC are divided into three large groups: the type 1 ILCs expressing T-bet (ILC1 and NK cells) implicated in defense against tumors and intracellular pathogens like viruses, the type 2 ILCs (ILC2) expressing GATA3 which are important in the defense against extracellular parasites, allergens and adipose tissue homeostasis, and the type 3 ILCs (ILC3) expressing RORγt implicated in gut homeostasis as well as immune responses against extracellular microbes such as bacteria and fungi. 1 In addition, among the ILC3 the Lymphoid Tissue Inducer (LTi) cells play a critical role in the embryonic lymph node (LN) formation 2 (Figure 1).Beside this classification, ILC are highly heterogenous within and across tissues. Numerous studies have shown that ILC are highly plastic and transdifferentiate in response to environmental cues depending on the tissue and the immune context. Also, in addition to tissue resident ILC deriving from the bone marrow (BM), 3 lineage restricted ILC can differentiate locally from progenitor cells in the fetal liver 4 and gut, 5 or from circulating precursors. 6 Most studies on the ILC ontogeny have been conducted in the adult mouse or human, mainly by in vitro differentiation or using transgenic and humanized mouse models (reviewed eg here 1,7 ) but increasingly more information becomes available on the presence of the ILCs within embryos (reviewed eg here 8-10 ). Summarized, all ILCs derive from the Flt-3 + common lymphoid progenitor (CLP) which resides either in the fetal liver (FL) or the bone-marrow.The expression of the transcription factors Tox and Nfil3 direct their differentiation toward an Il7R + α 4 ß 7 integrin + α-Lymphocyte Progenitor (αLP), and a subsequent αLP2 stage where Flt3 expression is downregulated, although the protein can still be observed.